TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive Medicare plans to cut oncology payments on Jan. 1 unless Congress intervenes. October 17, 2003